mRNA market expected to reach $48.65 billion by 2032 due to advancements in treatments.
From GlobeNewswire: 2024-12-08 08:00:00
The mRNA Therapeutics Market, valued at USD 11.82 billion in 2023, is projected to reach USD 48.65 billion by 2032 with a CAGR of 17.04%. The success of mRNA vaccines against COVID-19 has fueled investment in mRNA technologies for cancer, respiratory diseases, and genetic disorders, promising next-generation treatments.
Advancements in mRNA-based cancer therapies, expanding vaccine portfolios, and regulatory approvals are driving market growth. The ability to rapidly produce vaccines and therapeutics, along with partnerships and funding for clinical trials, are accelerating the market’s trajectory towards personalized medicine and disease treatment.
In 2023, infectious diseases led the mRNA therapeutics market, driven by successful COVID-19 vaccines. Oncology is expected to grow rapidly, with personalized cancer vaccines showing promise. Prophylactic vaccines dominated in 2023, while therapeutics are projected to grow significantly by 2032, especially in cancer therapy.
Hospitals & clinics represented the largest share in 2023, with growing demand for mRNA treatments. Specialty pharmacies are crucial for mRNA vaccine distribution, expected to fuel growth. North America led in 2023, followed by Europe, with Asia Pacific projected to experience the highest growth due to increasing healthcare investments and demand for innovative therapies. The Asia Pacific mRNA Therapeutics market is expected to grow due to personalized medicine and advanced healthcare technologies. Moderna, Inc. expanded its mRNA research to include oncology, respiratory diseases, and rare conditions in September 2023. SNS Insider offers a detailed report on the market dynamics, segmentation, and company profiles in the mRNA Therapeutics market from 2024-2032. SNS Insider is a leading global market research and consulting agency providing clients with accurate market data and insights for confident decision-making.
Read more at GlobeNewswire: mRNA Therapeutics Market Size to Hit USD 48.65 Billion by